Macababayao, Ethan G.
HRN: 23-82-18 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/30/2023
10/06/2023
IV
115mg
Q8
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes